1,219
Views
0
CrossRef citations to date
0
Altmetric
RESEARCH PAPER

Immunosuppressants exert antiviral effects against influenza A(H1N1)pdm09 virus via inhibition of nucleic acid synthesis, mRNA splicing, and protein stability

, , , , , , , , & show all
Article: 2301242 | Received 10 Aug 2023, Accepted 28 Dec 2023, Published online: 06 Feb 2024

References

  • Krammer F, Smith GJD, Fouchier RAM, et al. Influenza. Nat Rev Dis Primers. 2018;4(1):3. doi: 10.1038/s41572-018-0002-y
  • Hause BM, Collin EA, Liu R, et al. Characterization of a novel influenza virus in cattle and swine: proposal for a new genus in the Orthomyxoviridae family. MBio. 2014;5(2):e00031–11. doi: 10.1128/mBio.00031-14
  • Saraswathy N, Ramalingam P. 16 - Glycoproteomics. In: Saraswathy N P Ramalingam, editors. Concepts and techniques in genomics and proteomics. Woodhead Publishing; 2011. pp. 213–218. doi: 10.1533/9781908818058.213.
  • Gamblin SJ, Skehel JJ. Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins. J Biol Chem. 2010;285:28403–28409. doi: 10.1074/jbc.R110.129809
  • Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020;21(8):421–438. doi: 10.1038/s41580-020-0250-z
  • Inglis SC, Brown CM. Spliced and unspliced RNAs encoded by virion RNA segment 7 of influenza virus. Nucleic Acids Res. 1981;9(12):2727–2740. doi: 10.1093/nar/9.12.2727
  • Tsai PL, Chiou NT, Kuss S, et al. Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. PLOS Pathogens. 2013;9(6):9. doi: 10.1371/journal.ppat.1003460
  • Walti LN, Mugglin C, Mombelli M, et al. Vaccine-preventable infections among solid organ transplant recipients in Switzerland. JAMA Netw Open. 2023;6(4):e2310687. doi: 10.1001/jamanetworkopen.2023.10687
  • Kuiken T, van den Brand J, van Riel D, et al. Comparative pathology of select agent influenza a virus infections. Vet Pathol. 2010;47(5):893–914. doi: 10.1177/0300985810378651
  • Gu Y, Zuo X, Zhang S, et al. The Mechanism behind Influenza Virus Cytokine Storm. Viruses. 2021;13(7):1362. doi: 10.3390/v13071362
  • Liu Q, Zhou Y, Yang Z. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol. 2016;13(1):3–10. doi: 10.1038/cmi.2015.74
  • Ianevski A, Giri AK, Aittokallio T. SynergyFinder 2.0: visual analytics of multi-drug combination synergies. Nucleic Acids Res. 2020;48(W1):W488–93. doi: 10.1093/nar/gkaa216
  • Diamond MS, Zachariah M, Harris E. Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. Virology. 2002;304(2):211–221. doi: 10.1006/viro.2002.1685
  • Takhampunya R, Ubol S, Houng H-S, et al. Inhibition of dengue virus replication by mycophenolic acid and ribavirin. J Gen Virol. 2006;87(7):1947–1952. doi: 10.1099/vir.0.81655-0
  • Chan JFW, Chan K-H, Kao RYT, et al. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect. 2013;67(6):606–616. doi: 10.1016/j.jinf.2013.09.029
  • Dubois J, Terrier O, Rosa-Calatrava M, et al. Influenza viruses and mRNA splicing: doing more with less. MBio. 2014;5(3):e00070–14. doi: 10.1128/mBio.00070-14
  • Yeh Y-H, Jenike KM, Calvi RM, et al. Filgotinib suppresses HIV-1–driven gene transcription by inhibiting HIV-1 splicing and T cell activation. J Clin Invest. 2020;130(9):4969–4984. doi: 10.1172/JCI137371
  • Thompson MG, Muñoz-Moreno R, Bhat P, et al. Co-regulatory activity of hnRNP K and NS1-BP in influenza and human mRNA splicing. Nat Commun. 2018;9(1):2407. doi: 10.1038/s41467-018-04779-4
  • Razonable RR. Management of viral infections in solid organ transplant recipients. Expert Rev Anti Infect Ther. 2011;9:685–700. doi: 10.1586/eri.11.43
  • Shahani L, Ariza-Heredia EJ, Chemaly RF. Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev Anti Infect Ther. 2017;15:401–415. doi: 10.1080/14787210.2017.1279970
  • Dang W, Yin Y, Wang Y, et al. Inhibition of calcineurin or IMP dehydrogenase exerts moderate to potent antiviral activity against norovirus replication. Antimicrob Agents Chemother. 2017;61(11):e01095–17. doi: 10.1128/AAC.01095-17
  • Han Y, Duan X, Yang L, et al. Identification of SARS-CoV-2 Inhibitors using Lung and Colonic Organoids. Nature. 2021;589(7841):270–275. doi: 10.1038/s41586-020-2901-9
  • Pan Q, de Ruiter PE, Metselaar HJ, et al. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C virus infection in vitro and in vivo. Hepatology. 2012;55(6):1673–1683. doi: 10.1002/hep.25562
  • Hossain MM, Coull JJ, Drusano GL, et al. Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir. Antiviral Res. 2002;55:41–52. doi: 10.1016/s0166-3542(02)00006-2
  • Colmenero J, Rodríguez-Perálvarez M, Salcedo M, et al. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol. 2021;74:148–155. doi: 10.1016/j.jhep.2020.07.040
  • Chen D, Liu Y, Zhang F, et al. 6-thioguanine inhibits herpes simplex virus 1 infection of eyes. Microbiol Spectr. 2021;9(3):e0064621. doi: 10.1128/Spectrum.00646-21
  • Jiang W, Sheng C, Gu X, et al. Suppression of Rac1 signaling by influenza a virus NS1 facilitates viral replication. Sci Rep. 2016;6(1):1–16. doi: 10.1038/srep35041
  • Yin Y, Chen S, Hakim MS, et al. 6-thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling. Antiviral Res. 2018;156:92–101. doi: 10.1016/j.antiviral.2018.06.011
  • Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32(1):513–545. doi: 10.1146/annurev-immunol-032713-120231
  • Lee HK, Jung O, Hennighausen L. JAK inhibitors dampen activation of interferon-stimulated transcription of ACE2 isoforms in human airway epithelial cells. Commun Biol. 2021;4(1):654. doi: 10.1038/s42003-021-02167-1
  • Sajuthi SP, DeFord P, Li Y, et al. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium. Nat Commun. 2020;11(1):5139. doi: 10.1038/s41467-020-18781-2
  • Martin-Loeches I, Torres A. Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm? Eur Respir Rev. 2021;30(159):200346. doi: 10.1183/16000617.0346-2020